How have genetic and genomic studies influenced cancer therapy?
Genetic and genomic studies have had a profound impact on cancer therapy. By understanding the genetic mutations that drive cancer, researchers have been able to develop targeted therapies that specifically inhibit those mutations. Drugs like tyrosine kinase inhibitors and PARP inhibitors are examples of targeted therapies that have shown great promise in treating cancers with specific genetic abnormalities. This approach not only enhances the efficacy of treatments but also reduces side effects.
